Remove 2050 Remove Cannabinoids Remove Patients
article thumbnail

CBD: Exploring The Therapeutic Effects of Cannabis Without the High

Canna Care Docs

For those who might be exploring the benefits of cannabis or are considering its many therapeutic effects, Cannabidiol, often abbreviated as CBD is especially important for cannabis patients. CBD is one of close to 85 cannabinoids present in cannabis, with THC being the most commonly known. The Potential Value of CBD For Patients.

article thumbnail

Benefits of Cannabis for Alzheimer’s disease

Alchimia

Once the disease starts affecting the person, life expectancy greatly depends on patients (from 3 to 20 years), with an average of 8,5 years. Patient associations estimate that we’ll have around 1,5 million people suffering from Alzheimer in Spain by 2050. Cannabis patient. Source: Spanish Society of Neurology ).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Australia – Policy Analysis: Medicinal cannabis and driving: the intersection of health and road safety policy – “there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications”

Cannabis Law Report

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Daniel Perkins a b Hugh Brophy a Iain S. methadone) demonstrate a feasible alternative approach. Conclusion.

article thumbnail

Policy Analysis Paper: Medicinal cannabis and driving: the intersection of health and road safety policy

Cannabis Law Report

The application of presence-based offences to medicinal cannabis patients appears to derive from the historical status of cannabis as a prohibited drug with no legitimate medical application. The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia.

Policy 51
article thumbnail

Cannabis and Alzheimer’s Disease: The Compelling Evidence

Cannabis Cheri

Although it is considered a disease of the elderly, early onset Alzheimer’s can begin in the 40s and affects about 5 percent of all Alzheimer’s patients. Here’s why: In most Alzheimer’s patients, a reduction in the number of brain cells and fewer connections between the remaining brain cells occurs.

article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.). 2050 , 2051, 2075; Pub. 2050 , 2051, 2075; Pub. The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 301(a), Nov. 96–132 , §

Banking 45